Muhammad Zohaib Khan. “FREQUENCY OF END OF TREATMENT RESPONSE IN GENOTYPE 3 CIRRHOTIC PATIENTS TAKING SOFOSBUVIR, RIBAVIRIN AND DACLATASVIR”. Journal of Population Therapeutics and Clinical Pharmacology 31, no. 9 (September 25, 2024): 4104–4128. Accessed September 14, 2025. https://www.jptcp.com/index.php/jptcp/article/view/10033.